Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

A summary of employees’ stock options activities during the six months ended June 30, 2024 is as follows:

 

	Six Months Ended June 30, 2024 (unaudited)
	Number	Weighted average exercise price		Aggregate intrinsic value (in thousands)		Weighted average remaining contractual life (years)
Options outstanding as of January 1, 2024	573,430	$	7.564	$	21,627	0.962
Granted	—	$	—
Exercised	(535,668)	$	7.555
Forfeited and expired	—	$	—
Options outstanding and exercisable as of June 30, 2024	37,762	$	7.690	$	1,521	1.061

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

The options outstanding as of June 30, 2024 (unaudited) separated into exercise prices as follows:

Exercise price		Options outstanding and exercisable as of June 30, 2024	Weighted average remaining contractual life (years) of options outstanding and exercisable	Weighted average exercise price of options outstanding and exercisable
	$5.682	4,483	5.658	$	5.682
	$7.220	24,279	0.367	$	7.220
	$9.960	9,000	0.644	$	9.960
		37,762	1.061	$	7.690

Schedule of Outstanding Options

The Company’s outstanding options granted to consultants for services as of June 30, 2024 (unaudited) were as follows:

Grant date	Number of options outstanding and exercisable as of June 30, 2024	Range of exercise price per share					Exercisable through
November 2014 - February 2016	10,500	$	5.623	—	$	7.220	November 2024 - February 2026

Schedule of Share-based Payment Arrangement, Restricted Stock Unit and Performance Stock Unit Activity

A summary of RSUs and PSUs for employees, consultants and non-employee directors of the Company for the six months ended June 30, 2024 (unaudited) is as follows:

 

	Number of shares underlying outstanding RSUs and PSUs	Weighted- average grant date fair value
Unvested balance - January 1, 2024	8,234,171	$	36.83
Granted	3,557,660	$	42.66
Vested	(3,052,421)	$	40.20
Forfeited	(980,261)	$	38.87
Unvested balance – June 30, 2024	7,759,149	$	37.92

Schedule of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

 

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
	(unaudited)				(unaudited)
Cost of revenues	$	1,298	$	2,030	$	2,660	$	4,530
Research and development	8,856		13,634		20,615		26,157
Sales and marketing	10,655		13,898		21,125		26,660
General and administrative	9,280		9,822		17,782		17,848
Total	$	30,089	$	39,384	$	62,182	$	75,195